Biologics Outsourcing Market: Global Key Players, Trends, Share, Industry Size, Growth, Opportunities, Forecast To 2024
May 31, 2019 7:07 AM ET
Summary
WiseGuyReports.com adds “Biologics Outsourcing Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.
Outsourcing is increasing as a percentage of the whole manufacturing capacity due to relatively more of new product manufacturing is outsourced and facilities with products that become generic are non-core and are being divested.
This report focuses on the global Biologics Outsourcing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biologics Outsourcing development in United States, Europe and China.
The key players covered in this study
Boehringer Ingelheim
Catalent
GenScript
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Innovent Biologics
Selexis
Lonza
Abzena
Adimab
Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/4084220-global-biologics-outsourcing-market-size-status-and-forecast-2019-2025
Market segment by Type, the product can be split into
Antibody
Recombinant
Protein
Vaccines
Others
Market segment by Application, split into
Vaccine & Therapeutics Development
Blood & Blood Related Products Testing
Cellular and Gene Therapy
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Biologics Outsourcing status, future forecast, growth opportunity, key market and key players.
To present the Biologics Outsourcing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Biologics Outsourcing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Complete Report details @ https://www.wiseguyreports.com/reports/4084220-global-biologics-outsourcing-market-size-status-and-forecast-2019-2025
Major Key Points in Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biologics Outsourcing Market Size Growth Rate by Type (2014-2025)
1.4.2 Antibody
1.4.3 Recombinant
1.4.4 Protein
1.4.5 Vaccines
1.4.6 Others
1.5 Market by Application
1.5.1 Global Biologics Outsourcing Market Share by Application (2014-2025)
1.5.2 Vaccine & Therapeutics Development
1.5.3 Blood & Blood Related Products Testing
1.5.4 Cellular and Gene Therapy
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Biologics Outsourcing Market Size
2.2 Biologics Outsourcing Growth Trends by Regions
2.2.1 Biologics Outsourcing Market Size by Regions (2014-2025)
2.2.2 Biologics Outsourcing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
….
12 International Players Profiles
12.1 Boehringer Ingelheim
12.1.1 Boehringer Ingelheim Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biologics Outsourcing Introduction
12.1.4 Boehringer Ingelheim Revenue in Biologics Outsourcing Business (2014-2019)
12.1.5 Boehringer Ingelheim Recent Development
12.2 Catalent
12.2.1 Catalent Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biologics Outsourcing Introduction
12.2.4 Catalent Revenue in Biologics Outsourcing Business (2014-2019)
12.2.5 Catalent Recent Development
12.3 GenScript
12.3.1 GenScript Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biologics Outsourcing Introduction
12.3.4 GenScript Revenue in Biologics Outsourcing Business (2014-2019)
12.3.5 GenScript Recent Development
12.4 Innovent Biologics
12.4.1 Innovent Biologics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biologics Outsourcing Introduction
12.4.4 Innovent Biologics Revenue in Biologics Outsourcing Business (2014-2019)
12.4.5 Innovent Biologics Recent Development
12.5 Syngene
12.5.1 Syngene Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biologics Outsourcing Introduction
12.5.4 Syngene Revenue in Biologics Outsourcing Business (2014-2019)
12.5.5 Syngene Recent Development
12.6 Shanghai Medicilon
12.6.1 Shanghai Medicilon Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biologics Outsourcing Introduction
12.6.4 Shanghai Medicilon Revenue in Biologics Outsourcing Business (2014-2019)
12.6.5 Shanghai Medicilon Recent Development
12.7 GL Biochem Corporation
12.7.1 GL Biochem Corporation Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biologics Outsourcing Introduction
12.7.4 GL Biochem Corporation Revenue in Biologics Outsourcing Business (2014-2019)
12.7.5 GL Biochem Corporation Recent Development
12.8 GVK Biosciences Private
12.8.1 GVK Biosciences Private Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biologics Outsourcing Introduction
12.8.4 GVK Biosciences Private Revenue in Biologics Outsourcing Business (2014-2019)
12.8.5 GVK Biosciences Private Recent Development
12.9 Horizon Discovery Group
12.9.1 Horizon Discovery Group Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biologics Outsourcing Introduction
12.9.4 Horizon Discovery Group Revenue in Biologics Outsourcing Business (2014-2019)
12.9.5 Horizon Discovery Group Recent Development
12.10 Innovent Biologics
12.10.1 Innovent Biologics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Biologics Outsourcing Introduction
12.10.4 Innovent Biologics Revenue in Biologics Outsourcing Business (2014-2019)
12.10.5 Innovent Biologics Recent Development
12.11 Selexis
12.12 Lonza
12.13 Abzena
12.14 Adimab
Continued….
Contact Information:
Contact Us:
[email protected]
Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)
Tags:
Research, Research Newswire, English